nodes	percent_of_prediction	percent_of_DWPC	metapath
Pemetrexed—Folic Acid Metabolism Inhibitors—Methotrexate—stomach cancer	0.322	1	CiPCiCtD
Pemetrexed—Methotrexate—stomach cancer	0.21	1	CrCtD
Pemetrexed—TYMS—stomach cancer	0.0868	1	CbGaD
Pemetrexed—TYMS—Floxuridine—stomach cancer	0.0688	0.404	CbGbCtD
Pemetrexed—Raltitrexed—Methotrexate—stomach cancer	0.0277	0.2	CrCrCtD
Pemetrexed—Tetrahydrofolic acid—Methotrexate—stomach cancer	0.0277	0.2	CrCrCtD
Pemetrexed—Folic Acid—Methotrexate—stomach cancer	0.0277	0.2	CrCrCtD
Pemetrexed—Leucovorin—Methotrexate—stomach cancer	0.0277	0.2	CrCrCtD
Pemetrexed—Pralatrexate—Methotrexate—stomach cancer	0.0277	0.2	CrCrCtD
Pemetrexed—TYMS—Capecitabine—stomach cancer	0.0216	0.127	CbGbCtD
Pemetrexed—ATIC—Methotrexate—stomach cancer	0.02	0.118	CbGbCtD
Pemetrexed—SLC46A1—Methotrexate—stomach cancer	0.0159	0.0934	CbGbCtD
Pemetrexed—SLC29A1—Fluorouracil—stomach cancer	0.0138	0.0814	CbGbCtD
Pemetrexed—TYMS—Fluorouracil—stomach cancer	0.0128	0.0754	CbGbCtD
Pemetrexed—DHFR—Methotrexate—stomach cancer	0.0102	0.0597	CbGbCtD
Pemetrexed—TYMS—Methotrexate—stomach cancer	0.00707	0.0416	CbGbCtD
Pemetrexed—GART—hematopoietic system—stomach cancer	0.000634	0.0459	CbGeAlD
Pemetrexed—GART—pancreas—stomach cancer	0.000516	0.0374	CbGeAlD
Pemetrexed—SLC46A1—hematopoietic system—stomach cancer	0.000514	0.0373	CbGeAlD
Pemetrexed—GART—lymphoid tissue—stomach cancer	0.000446	0.0323	CbGeAlD
Pemetrexed—GART—digestive system—stomach cancer	0.000441	0.0319	CbGeAlD
Pemetrexed—ATIC—hematopoietic system—stomach cancer	0.00043	0.0312	CbGeAlD
Pemetrexed—GART—bone marrow—stomach cancer	0.000406	0.0294	CbGeAlD
Pemetrexed—ATIC—epithelium—stomach cancer	0.000393	0.0285	CbGeAlD
Pemetrexed—ATIC—smooth muscle tissue—stomach cancer	0.000379	0.0275	CbGeAlD
Pemetrexed—GART—endocrine gland—stomach cancer	0.000364	0.0264	CbGeAlD
Pemetrexed—SLC46A1—lymphoid tissue—stomach cancer	0.000362	0.0262	CbGeAlD
Pemetrexed—SLC46A1—digestive system—stomach cancer	0.000358	0.0259	CbGeAlD
Pemetrexed—ATIC—pancreas—stomach cancer	0.00035	0.0254	CbGeAlD
Pemetrexed—GART—liver—stomach cancer	0.000328	0.0238	CbGeAlD
Pemetrexed—DCK—Topotecan—Irinotecan—stomach cancer	0.000324	0.505	CbGdCrCtD
Pemetrexed—ATIC—lymphoid tissue—stomach cancer	0.000303	0.0219	CbGeAlD
Pemetrexed—ATIC—digestive system—stomach cancer	0.000299	0.0217	CbGeAlD
Pemetrexed—SLC46A1—endocrine gland—stomach cancer	0.000296	0.0214	CbGeAlD
Pemetrexed—TYMS—hematopoietic system—stomach cancer	0.000292	0.0211	CbGeAlD
Pemetrexed—DHFR—hematopoietic system—stomach cancer	0.000289	0.0209	CbGeAlD
Pemetrexed—SLC46A1—liver—stomach cancer	0.000266	0.0193	CbGeAlD
Pemetrexed—SLC29A1—hematopoietic system—stomach cancer	0.000262	0.019	CbGeAlD
Pemetrexed—TYMS—smooth muscle tissue—stomach cancer	0.000257	0.0186	CbGeAlD
Pemetrexed—GART—lymph node—stomach cancer	0.000252	0.0182	CbGeAlD
Pemetrexed—DCK—hematopoietic system—stomach cancer	0.00025	0.0181	CbGeAlD
Pemetrexed—ATIC—endocrine gland—stomach cancer	0.000247	0.0179	CbGeAlD
Pemetrexed—Raltitrexed—TYMS—stomach cancer	0.000241	0.251	CrCbGaD
Pemetrexed—ATIC—liver—stomach cancer	0.000223	0.0161	CbGeAlD
Pemetrexed—SLC29A1—pancreas—stomach cancer	0.000213	0.0154	CbGeAlD
Pemetrexed—TYMS—lymphoid tissue—stomach cancer	0.000205	0.0149	CbGeAlD
Pemetrexed—SLC46A1—lymph node—stomach cancer	0.000204	0.0148	CbGeAlD
Pemetrexed—DCK—pancreas—stomach cancer	0.000204	0.0147	CbGeAlD
Pemetrexed—DHFR—lymphoid tissue—stomach cancer	0.000203	0.0147	CbGeAlD
Pemetrexed—TYMS—digestive system—stomach cancer	0.000203	0.0147	CbGeAlD
Pemetrexed—DHFR—digestive system—stomach cancer	0.000201	0.0146	CbGeAlD
Pemetrexed—TYMS—bone marrow—stomach cancer	0.000187	0.0136	CbGeAlD
Pemetrexed—DHFR—bone marrow—stomach cancer	0.000185	0.0134	CbGeAlD
Pemetrexed—SLC29A1—lymphoid tissue—stomach cancer	0.000184	0.0133	CbGeAlD
Pemetrexed—Leucovorin—TYMS—stomach cancer	0.000182	0.19	CrCbGaD
Pemetrexed—Pralatrexate—TYMS—stomach cancer	0.000182	0.19	CrCbGaD
Pemetrexed—SLC29A1—digestive system—stomach cancer	0.000182	0.0132	CbGeAlD
Pemetrexed—DCK—lymphoid tissue—stomach cancer	0.000176	0.0127	CbGeAlD
Pemetrexed—DCK—digestive system—stomach cancer	0.000174	0.0126	CbGeAlD
Pemetrexed—TYMS—Paclitaxel—Docetaxel—stomach cancer	0.000171	0.267	CbGdCrCtD
Pemetrexed—ATIC—lymph node—stomach cancer	0.000171	0.0124	CbGeAlD
Pemetrexed—SLC29A1—bone marrow—stomach cancer	0.000168	0.0122	CbGeAlD
Pemetrexed—TYMS—endocrine gland—stomach cancer	0.000168	0.0121	CbGeAlD
Pemetrexed—DHFR—endocrine gland—stomach cancer	0.000166	0.012	CbGeAlD
Pemetrexed—DCK—bone marrow—stomach cancer	0.00016	0.0116	CbGeAlD
Pemetrexed—TYMS—liver—stomach cancer	0.000151	0.011	CbGeAlD
Pemetrexed—SLC29A1—endocrine gland—stomach cancer	0.00015	0.0109	CbGeAlD
Pemetrexed—DHFR—liver—stomach cancer	0.00015	0.0108	CbGeAlD
Pemetrexed—DCK—endocrine gland—stomach cancer	0.000144	0.0104	CbGeAlD
Pemetrexed—SLC29A1—liver—stomach cancer	0.000136	0.00982	CbGeAlD
Pemetrexed—DCK—liver—stomach cancer	0.00013	0.00938	CbGeAlD
Pemetrexed—TYMS—lymph node—stomach cancer	0.000116	0.0084	CbGeAlD
Pemetrexed—DHFR—lymph node—stomach cancer	0.000115	0.00831	CbGeAlD
Pemetrexed—SLC29A1—lymph node—stomach cancer	0.000104	0.00753	CbGeAlD
Pemetrexed—DCK—lymph node—stomach cancer	9.93e-05	0.00719	CbGeAlD
Pemetrexed—Folic Acid—MTHFR—stomach cancer	9.35e-05	0.0976	CrCbGaD
Pemetrexed—Tetrahydrofolic acid—MTHFR—stomach cancer	9.35e-05	0.0976	CrCbGaD
Pemetrexed—Methotrexate—TYMS—stomach cancer	8.04e-05	0.0839	CrCbGaD
Pemetrexed—DCK—Doxorubicin—Epirubicin—stomach cancer	7.62e-05	0.119	CbGdCrCtD
Pemetrexed—DCK—Epirubicin—Doxorubicin—stomach cancer	7.05e-05	0.11	CbGdCrCtD
Pemetrexed—Methotrexate—MTHFR—stomach cancer	6.39e-05	0.0667	CrCbGaD
Pemetrexed—Loss of consciousness—Docetaxel—stomach cancer	2.32e-05	0.000759	CcSEcCtD
Pemetrexed—Pancreatitis—Doxorubicin—stomach cancer	2.32e-05	0.000759	CcSEcCtD
Pemetrexed—Angina pectoris—Doxorubicin—stomach cancer	2.3e-05	0.000754	CcSEcCtD
Pemetrexed—Hepatobiliary disease—Methotrexate—stomach cancer	2.3e-05	0.000753	CcSEcCtD
Pemetrexed—Hypersensitivity—Irinotecan—stomach cancer	2.3e-05	0.000751	CcSEcCtD
Pemetrexed—Syncope—Capecitabine—stomach cancer	2.29e-05	0.00075	CcSEcCtD
Pemetrexed—Leukopenia—Capecitabine—stomach cancer	2.29e-05	0.000749	CcSEcCtD
Pemetrexed—Hypertension—Docetaxel—stomach cancer	2.28e-05	0.000746	CcSEcCtD
Pemetrexed—Infestation NOS—Epirubicin—stomach cancer	2.28e-05	0.000746	CcSEcCtD
Pemetrexed—Infestation—Epirubicin—stomach cancer	2.28e-05	0.000746	CcSEcCtD
Pemetrexed—Agranulocytosis—Methotrexate—stomach cancer	2.27e-05	0.000744	CcSEcCtD
Pemetrexed—Stevens-Johnson syndrome—Epirubicin—stomach cancer	2.26e-05	0.000739	CcSEcCtD
Pemetrexed—Myalgia—Docetaxel—stomach cancer	2.25e-05	0.000735	CcSEcCtD
Pemetrexed—Arthralgia—Docetaxel—stomach cancer	2.25e-05	0.000735	CcSEcCtD
Pemetrexed—Chest pain—Docetaxel—stomach cancer	2.25e-05	0.000735	CcSEcCtD
Pemetrexed—Loss of consciousness—Capecitabine—stomach cancer	2.25e-05	0.000735	CcSEcCtD
Pemetrexed—Pancytopenia—Doxorubicin—stomach cancer	2.25e-05	0.000735	CcSEcCtD
Pemetrexed—Renal failure—Epirubicin—stomach cancer	2.24e-05	0.000733	CcSEcCtD
Pemetrexed—Asthenia—Irinotecan—stomach cancer	2.24e-05	0.000732	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Epirubicin—stomach cancer	2.23e-05	0.000731	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	2.23e-05	0.00073	CcSEcCtD
Pemetrexed—Stomatitis—Epirubicin—stomach cancer	2.22e-05	0.000727	CcSEcCtD
Pemetrexed—Conjunctivitis—Epirubicin—stomach cancer	2.21e-05	0.000725	CcSEcCtD
Pemetrexed—Neutropenia—Doxorubicin—stomach cancer	2.21e-05	0.000724	CcSEcCtD
Pemetrexed—Hypertension—Capecitabine—stomach cancer	2.21e-05	0.000722	CcSEcCtD
Pemetrexed—Hypersensitivity—Fluorouracil—stomach cancer	2.2e-05	0.00072	CcSEcCtD
Pemetrexed—Hepatitis—Methotrexate—stomach cancer	2.19e-05	0.000715	CcSEcCtD
Pemetrexed—Arthralgia—Capecitabine—stomach cancer	2.18e-05	0.000712	CcSEcCtD
Pemetrexed—Chest pain—Capecitabine—stomach cancer	2.18e-05	0.000712	CcSEcCtD
Pemetrexed—Myalgia—Capecitabine—stomach cancer	2.18e-05	0.000712	CcSEcCtD
Pemetrexed—Pharyngitis—Methotrexate—stomach cancer	2.17e-05	0.00071	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	2.16e-05	0.000707	CcSEcCtD
Pemetrexed—Urinary tract disorder—Methotrexate—stomach cancer	2.16e-05	0.000706	CcSEcCtD
Pemetrexed—Hepatobiliary disease—Epirubicin—stomach cancer	2.15e-05	0.000705	CcSEcCtD
Pemetrexed—Anaphylactic shock—Docetaxel—stomach cancer	2.15e-05	0.000705	CcSEcCtD
Pemetrexed—Oedema—Docetaxel—stomach cancer	2.15e-05	0.000705	CcSEcCtD
Pemetrexed—Urethral disorder—Methotrexate—stomach cancer	2.14e-05	0.000701	CcSEcCtD
Pemetrexed—Infection—Docetaxel—stomach cancer	2.14e-05	0.0007	CcSEcCtD
Pemetrexed—Methotrexate—ALB—stomach cancer	2.14e-05	0.0223	CrCbGaD
Pemetrexed—Diarrhoea—Irinotecan—stomach cancer	2.13e-05	0.000698	CcSEcCtD
Pemetrexed—Agranulocytosis—Epirubicin—stomach cancer	2.13e-05	0.000696	CcSEcCtD
Pemetrexed—Shock—Docetaxel—stomach cancer	2.12e-05	0.000694	CcSEcCtD
Pemetrexed—Nervous system disorder—Docetaxel—stomach cancer	2.11e-05	0.000691	CcSEcCtD
Pemetrexed—Pruritus—Fluorouracil—stomach cancer	2.11e-05	0.000691	CcSEcCtD
Pemetrexed—Thrombocytopenia—Docetaxel—stomach cancer	2.11e-05	0.00069	CcSEcCtD
Pemetrexed—Infestation NOS—Doxorubicin—stomach cancer	2.11e-05	0.00069	CcSEcCtD
Pemetrexed—Infestation—Doxorubicin—stomach cancer	2.11e-05	0.00069	CcSEcCtD
Pemetrexed—Skin disorder—Docetaxel—stomach cancer	2.09e-05	0.000685	CcSEcCtD
Pemetrexed—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	2.09e-05	0.000684	CcSEcCtD
Pemetrexed—Oedema—Capecitabine—stomach cancer	2.09e-05	0.000683	CcSEcCtD
Pemetrexed—Renal failure—Doxorubicin—stomach cancer	2.07e-05	0.000678	CcSEcCtD
Pemetrexed—Infection—Capecitabine—stomach cancer	2.07e-05	0.000678	CcSEcCtD
Pemetrexed—Erythema multiforme—Methotrexate—stomach cancer	2.07e-05	0.000676	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Doxorubicin—stomach cancer	2.07e-05	0.000676	CcSEcCtD
Pemetrexed—Dizziness—Irinotecan—stomach cancer	2.06e-05	0.000674	CcSEcCtD
Pemetrexed—Stomatitis—Doxorubicin—stomach cancer	2.05e-05	0.000672	CcSEcCtD
Pemetrexed—Anorexia—Docetaxel—stomach cancer	2.05e-05	0.000672	CcSEcCtD
Pemetrexed—Shock—Capecitabine—stomach cancer	2.05e-05	0.000672	CcSEcCtD
Pemetrexed—Conjunctivitis—Doxorubicin—stomach cancer	2.05e-05	0.000671	CcSEcCtD
Pemetrexed—Nervous system disorder—Capecitabine—stomach cancer	2.05e-05	0.000669	CcSEcCtD
Pemetrexed—Hepatitis—Epirubicin—stomach cancer	2.05e-05	0.000669	CcSEcCtD
Pemetrexed—Eye disorder—Methotrexate—stomach cancer	2.04e-05	0.000668	CcSEcCtD
Pemetrexed—Diarrhoea—Fluorouracil—stomach cancer	2.04e-05	0.000668	CcSEcCtD
Pemetrexed—Thrombocytopenia—Capecitabine—stomach cancer	2.04e-05	0.000668	CcSEcCtD
Pemetrexed—Pharyngitis—Epirubicin—stomach cancer	2.03e-05	0.000664	CcSEcCtD
Pemetrexed—Skin disorder—Capecitabine—stomach cancer	2.03e-05	0.000663	CcSEcCtD
Pemetrexed—Urinary tract disorder—Epirubicin—stomach cancer	2.02e-05	0.000661	CcSEcCtD
Pemetrexed—Urethral disorder—Epirubicin—stomach cancer	2e-05	0.000656	CcSEcCtD
Pemetrexed—Hepatobiliary disease—Doxorubicin—stomach cancer	1.99e-05	0.000652	CcSEcCtD
Pemetrexed—Anorexia—Capecitabine—stomach cancer	1.99e-05	0.000651	CcSEcCtD
Pemetrexed—Vomiting—Irinotecan—stomach cancer	1.98e-05	0.000648	CcSEcCtD
Pemetrexed—Dizziness—Fluorouracil—stomach cancer	1.97e-05	0.000646	CcSEcCtD
Pemetrexed—Agranulocytosis—Doxorubicin—stomach cancer	1.97e-05	0.000644	CcSEcCtD
Pemetrexed—Rash—Irinotecan—stomach cancer	1.96e-05	0.000643	CcSEcCtD
Pemetrexed—Dermatitis—Irinotecan—stomach cancer	1.96e-05	0.000642	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Docetaxel—stomach cancer	1.96e-05	0.000642	CcSEcCtD
Pemetrexed—Erythema multiforme—Epirubicin—stomach cancer	1.93e-05	0.000633	CcSEcCtD
Pemetrexed—Alopecia—Methotrexate—stomach cancer	1.93e-05	0.000632	CcSEcCtD
Pemetrexed—Dyspnoea—Docetaxel—stomach cancer	1.92e-05	0.000629	CcSEcCtD
Pemetrexed—Eye disorder—Epirubicin—stomach cancer	1.91e-05	0.000626	CcSEcCtD
Pemetrexed—Erythema—Methotrexate—stomach cancer	1.9e-05	0.000623	CcSEcCtD
Pemetrexed—Malnutrition—Methotrexate—stomach cancer	1.9e-05	0.000623	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Capecitabine—stomach cancer	1.9e-05	0.000622	CcSEcCtD
Pemetrexed—Vomiting—Fluorouracil—stomach cancer	1.9e-05	0.000621	CcSEcCtD
Pemetrexed—Dyspepsia—Docetaxel—stomach cancer	1.9e-05	0.000621	CcSEcCtD
Pemetrexed—Hepatitis—Doxorubicin—stomach cancer	1.89e-05	0.000619	CcSEcCtD
Pemetrexed—Rash—Fluorouracil—stomach cancer	1.88e-05	0.000616	CcSEcCtD
Pemetrexed—Dermatitis—Fluorouracil—stomach cancer	1.88e-05	0.000615	CcSEcCtD
Pemetrexed—Pharyngitis—Doxorubicin—stomach cancer	1.88e-05	0.000615	CcSEcCtD
Pemetrexed—Decreased appetite—Docetaxel—stomach cancer	1.87e-05	0.000613	CcSEcCtD
Pemetrexed—Urinary tract disorder—Doxorubicin—stomach cancer	1.87e-05	0.000612	CcSEcCtD
Pemetrexed—Dysgeusia—Methotrexate—stomach cancer	1.86e-05	0.00061	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Docetaxel—stomach cancer	1.86e-05	0.000609	CcSEcCtD
Pemetrexed—Dyspnoea—Capecitabine—stomach cancer	1.86e-05	0.000609	CcSEcCtD
Pemetrexed—Fatigue—Docetaxel—stomach cancer	1.86e-05	0.000608	CcSEcCtD
Pemetrexed—Urethral disorder—Doxorubicin—stomach cancer	1.85e-05	0.000607	CcSEcCtD
Pemetrexed—Nausea—Irinotecan—stomach cancer	1.85e-05	0.000606	CcSEcCtD
Pemetrexed—Constipation—Docetaxel—stomach cancer	1.84e-05	0.000603	CcSEcCtD
Pemetrexed—Pain—Docetaxel—stomach cancer	1.84e-05	0.000603	CcSEcCtD
Pemetrexed—Dyspepsia—Capecitabine—stomach cancer	1.84e-05	0.000601	CcSEcCtD
Pemetrexed—Arrhythmia—Epirubicin—stomach cancer	1.83e-05	0.000598	CcSEcCtD
Pemetrexed—Decreased appetite—Capecitabine—stomach cancer	1.81e-05	0.000593	CcSEcCtD
Pemetrexed—Alopecia—Epirubicin—stomach cancer	1.81e-05	0.000591	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Capecitabine—stomach cancer	1.8e-05	0.000589	CcSEcCtD
Pemetrexed—Fatigue—Capecitabine—stomach cancer	1.8e-05	0.000588	CcSEcCtD
Pemetrexed—Erythema multiforme—Doxorubicin—stomach cancer	1.79e-05	0.000586	CcSEcCtD
Pemetrexed—Pain—Capecitabine—stomach cancer	1.78e-05	0.000584	CcSEcCtD
Pemetrexed—Constipation—Capecitabine—stomach cancer	1.78e-05	0.000584	CcSEcCtD
Pemetrexed—Erythema—Epirubicin—stomach cancer	1.78e-05	0.000583	CcSEcCtD
Pemetrexed—Malnutrition—Epirubicin—stomach cancer	1.78e-05	0.000583	CcSEcCtD
Pemetrexed—Nausea—Fluorouracil—stomach cancer	1.77e-05	0.00058	CcSEcCtD
Pemetrexed—Eye disorder—Doxorubicin—stomach cancer	1.77e-05	0.000579	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Docetaxel—stomach cancer	1.76e-05	0.000577	CcSEcCtD
Pemetrexed—Anaemia—Methotrexate—stomach cancer	1.76e-05	0.000575	CcSEcCtD
Pemetrexed—Dysgeusia—Epirubicin—stomach cancer	1.74e-05	0.000571	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Capecitabine—stomach cancer	1.71e-05	0.000558	CcSEcCtD
Pemetrexed—Body temperature increased—Docetaxel—stomach cancer	1.7e-05	0.000557	CcSEcCtD
Pemetrexed—Abdominal pain—Docetaxel—stomach cancer	1.7e-05	0.000557	CcSEcCtD
Pemetrexed—Leukopenia—Methotrexate—stomach cancer	1.7e-05	0.000557	CcSEcCtD
Pemetrexed—Arrhythmia—Doxorubicin—stomach cancer	1.69e-05	0.000553	CcSEcCtD
Pemetrexed—Alopecia—Doxorubicin—stomach cancer	1.67e-05	0.000547	CcSEcCtD
Pemetrexed—Urticaria—Capecitabine—stomach cancer	1.66e-05	0.000542	CcSEcCtD
Pemetrexed—Body temperature increased—Capecitabine—stomach cancer	1.65e-05	0.00054	CcSEcCtD
Pemetrexed—Abdominal pain—Capecitabine—stomach cancer	1.65e-05	0.00054	CcSEcCtD
Pemetrexed—Erythema—Doxorubicin—stomach cancer	1.65e-05	0.000539	CcSEcCtD
Pemetrexed—Malnutrition—Doxorubicin—stomach cancer	1.65e-05	0.000539	CcSEcCtD
Pemetrexed—Anaemia—Epirubicin—stomach cancer	1.65e-05	0.000539	CcSEcCtD
Pemetrexed—Arthralgia—Methotrexate—stomach cancer	1.62e-05	0.00053	CcSEcCtD
Pemetrexed—Chest pain—Methotrexate—stomach cancer	1.62e-05	0.00053	CcSEcCtD
Pemetrexed—Myalgia—Methotrexate—stomach cancer	1.62e-05	0.00053	CcSEcCtD
Pemetrexed—Dysgeusia—Doxorubicin—stomach cancer	1.61e-05	0.000528	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	1.61e-05	0.000526	CcSEcCtD
Pemetrexed—Syncope—Epirubicin—stomach cancer	1.6e-05	0.000523	CcSEcCtD
Pemetrexed—Leukopenia—Epirubicin—stomach cancer	1.59e-05	0.000522	CcSEcCtD
Pemetrexed—Hypersensitivity—Docetaxel—stomach cancer	1.59e-05	0.000519	CcSEcCtD
Pemetrexed—Loss of consciousness—Epirubicin—stomach cancer	1.56e-05	0.000512	CcSEcCtD
Pemetrexed—Anaphylactic shock—Methotrexate—stomach cancer	1.55e-05	0.000508	CcSEcCtD
Pemetrexed—Asthenia—Docetaxel—stomach cancer	1.55e-05	0.000506	CcSEcCtD
Pemetrexed—Infection—Methotrexate—stomach cancer	1.54e-05	0.000505	CcSEcCtD
Pemetrexed—Hypertension—Epirubicin—stomach cancer	1.54e-05	0.000503	CcSEcCtD
Pemetrexed—Hypersensitivity—Capecitabine—stomach cancer	1.54e-05	0.000503	CcSEcCtD
Pemetrexed—Pruritus—Docetaxel—stomach cancer	1.52e-05	0.000499	CcSEcCtD
Pemetrexed—Nervous system disorder—Methotrexate—stomach cancer	1.52e-05	0.000498	CcSEcCtD
Pemetrexed—Anaemia—Doxorubicin—stomach cancer	1.52e-05	0.000498	CcSEcCtD
Pemetrexed—Thrombocytopenia—Methotrexate—stomach cancer	1.52e-05	0.000498	CcSEcCtD
Pemetrexed—Arthralgia—Epirubicin—stomach cancer	1.52e-05	0.000496	CcSEcCtD
Pemetrexed—Myalgia—Epirubicin—stomach cancer	1.52e-05	0.000496	CcSEcCtD
Pemetrexed—Chest pain—Epirubicin—stomach cancer	1.52e-05	0.000496	CcSEcCtD
Pemetrexed—Skin disorder—Methotrexate—stomach cancer	1.51e-05	0.000494	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	1.51e-05	0.000493	CcSEcCtD
Pemetrexed—Asthenia—Capecitabine—stomach cancer	1.5e-05	0.00049	CcSEcCtD
Pemetrexed—Anorexia—Methotrexate—stomach cancer	1.48e-05	0.000484	CcSEcCtD
Pemetrexed—Syncope—Doxorubicin—stomach cancer	1.48e-05	0.000483	CcSEcCtD
Pemetrexed—Pruritus—Capecitabine—stomach cancer	1.48e-05	0.000483	CcSEcCtD
Pemetrexed—Leukopenia—Doxorubicin—stomach cancer	1.47e-05	0.000483	CcSEcCtD
Pemetrexed—Diarrhoea—Docetaxel—stomach cancer	1.47e-05	0.000482	CcSEcCtD
Pemetrexed—Anaphylactic shock—Epirubicin—stomach cancer	1.45e-05	0.000476	CcSEcCtD
Pemetrexed—Oedema—Epirubicin—stomach cancer	1.45e-05	0.000476	CcSEcCtD
Pemetrexed—Loss of consciousness—Doxorubicin—stomach cancer	1.45e-05	0.000474	CcSEcCtD
Pemetrexed—Infection—Epirubicin—stomach cancer	1.44e-05	0.000472	CcSEcCtD
Pemetrexed—Shock—Epirubicin—stomach cancer	1.43e-05	0.000468	CcSEcCtD
Pemetrexed—Diarrhoea—Capecitabine—stomach cancer	1.43e-05	0.000467	CcSEcCtD
Pemetrexed—Nervous system disorder—Epirubicin—stomach cancer	1.42e-05	0.000466	CcSEcCtD
Pemetrexed—Dizziness—Docetaxel—stomach cancer	1.42e-05	0.000466	CcSEcCtD
Pemetrexed—Thrombocytopenia—Epirubicin—stomach cancer	1.42e-05	0.000466	CcSEcCtD
Pemetrexed—Hypertension—Doxorubicin—stomach cancer	1.42e-05	0.000465	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Methotrexate—stomach cancer	1.41e-05	0.000463	CcSEcCtD
Pemetrexed—Skin disorder—Epirubicin—stomach cancer	1.41e-05	0.000462	CcSEcCtD
Pemetrexed—Arthralgia—Doxorubicin—stomach cancer	1.4e-05	0.000459	CcSEcCtD
Pemetrexed—Myalgia—Doxorubicin—stomach cancer	1.4e-05	0.000459	CcSEcCtD
Pemetrexed—Chest pain—Doxorubicin—stomach cancer	1.4e-05	0.000459	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	1.39e-05	0.000456	CcSEcCtD
Pemetrexed—Anorexia—Epirubicin—stomach cancer	1.39e-05	0.000453	CcSEcCtD
Pemetrexed—Dyspnoea—Methotrexate—stomach cancer	1.38e-05	0.000453	CcSEcCtD
Pemetrexed—Dizziness—Capecitabine—stomach cancer	1.38e-05	0.000451	CcSEcCtD
Pemetrexed—Vomiting—Docetaxel—stomach cancer	1.37e-05	0.000448	CcSEcCtD
Pemetrexed—Dyspepsia—Methotrexate—stomach cancer	1.37e-05	0.000447	CcSEcCtD
Pemetrexed—Rash—Docetaxel—stomach cancer	1.36e-05	0.000445	CcSEcCtD
Pemetrexed—Dermatitis—Docetaxel—stomach cancer	1.36e-05	0.000444	CcSEcCtD
Pemetrexed—Decreased appetite—Methotrexate—stomach cancer	1.35e-05	0.000442	CcSEcCtD
Pemetrexed—Anaphylactic shock—Doxorubicin—stomach cancer	1.34e-05	0.00044	CcSEcCtD
Pemetrexed—Oedema—Doxorubicin—stomach cancer	1.34e-05	0.00044	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Methotrexate—stomach cancer	1.34e-05	0.000439	CcSEcCtD
Pemetrexed—Fatigue—Methotrexate—stomach cancer	1.34e-05	0.000438	CcSEcCtD
Pemetrexed—Infection—Doxorubicin—stomach cancer	1.34e-05	0.000437	CcSEcCtD
Pemetrexed—Pain—Methotrexate—stomach cancer	1.33e-05	0.000435	CcSEcCtD
Pemetrexed—Vomiting—Capecitabine—stomach cancer	1.33e-05	0.000434	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Epirubicin—stomach cancer	1.32e-05	0.000433	CcSEcCtD
Pemetrexed—Shock—Doxorubicin—stomach cancer	1.32e-05	0.000433	CcSEcCtD
Pemetrexed—Nervous system disorder—Doxorubicin—stomach cancer	1.32e-05	0.000431	CcSEcCtD
Pemetrexed—Thrombocytopenia—Doxorubicin—stomach cancer	1.32e-05	0.000431	CcSEcCtD
Pemetrexed—Rash—Capecitabine—stomach cancer	1.32e-05	0.00043	CcSEcCtD
Pemetrexed—Dermatitis—Capecitabine—stomach cancer	1.31e-05	0.00043	CcSEcCtD
Pemetrexed—Skin disorder—Doxorubicin—stomach cancer	1.31e-05	0.000427	CcSEcCtD
Pemetrexed—Dyspnoea—Epirubicin—stomach cancer	1.3e-05	0.000424	CcSEcCtD
Pemetrexed—Anorexia—Doxorubicin—stomach cancer	1.28e-05	0.000419	CcSEcCtD
Pemetrexed—Nausea—Docetaxel—stomach cancer	1.28e-05	0.000419	CcSEcCtD
Pemetrexed—Dyspepsia—Epirubicin—stomach cancer	1.28e-05	0.000419	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Methotrexate—stomach cancer	1.27e-05	0.000416	CcSEcCtD
Pemetrexed—Decreased appetite—Epirubicin—stomach cancer	1.26e-05	0.000413	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Epirubicin—stomach cancer	1.25e-05	0.000411	CcSEcCtD
Pemetrexed—Fatigue—Epirubicin—stomach cancer	1.25e-05	0.00041	CcSEcCtD
Pemetrexed—Constipation—Epirubicin—stomach cancer	1.24e-05	0.000407	CcSEcCtD
Pemetrexed—Pain—Epirubicin—stomach cancer	1.24e-05	0.000407	CcSEcCtD
Pemetrexed—Nausea—Capecitabine—stomach cancer	1.24e-05	0.000405	CcSEcCtD
Pemetrexed—Urticaria—Methotrexate—stomach cancer	1.23e-05	0.000404	CcSEcCtD
Pemetrexed—Body temperature increased—Methotrexate—stomach cancer	1.23e-05	0.000402	CcSEcCtD
Pemetrexed—Abdominal pain—Methotrexate—stomach cancer	1.23e-05	0.000402	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Doxorubicin—stomach cancer	1.22e-05	0.000401	CcSEcCtD
Pemetrexed—Dyspnoea—Doxorubicin—stomach cancer	1.2e-05	0.000392	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Epirubicin—stomach cancer	1.19e-05	0.000389	CcSEcCtD
Pemetrexed—Dyspepsia—Doxorubicin—stomach cancer	1.18e-05	0.000387	CcSEcCtD
Pemetrexed—Decreased appetite—Doxorubicin—stomach cancer	1.17e-05	0.000382	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Doxorubicin—stomach cancer	1.16e-05	0.00038	CcSEcCtD
Pemetrexed—Fatigue—Doxorubicin—stomach cancer	1.16e-05	0.000379	CcSEcCtD
Pemetrexed—Urticaria—Epirubicin—stomach cancer	1.15e-05	0.000378	CcSEcCtD
Pemetrexed—Pain—Doxorubicin—stomach cancer	1.15e-05	0.000376	CcSEcCtD
Pemetrexed—Constipation—Doxorubicin—stomach cancer	1.15e-05	0.000376	CcSEcCtD
Pemetrexed—Abdominal pain—Epirubicin—stomach cancer	1.15e-05	0.000376	CcSEcCtD
Pemetrexed—Body temperature increased—Epirubicin—stomach cancer	1.15e-05	0.000376	CcSEcCtD
Pemetrexed—Hypersensitivity—Methotrexate—stomach cancer	1.14e-05	0.000374	CcSEcCtD
Pemetrexed—Asthenia—Methotrexate—stomach cancer	1.11e-05	0.000365	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Doxorubicin—stomach cancer	1.1e-05	0.00036	CcSEcCtD
Pemetrexed—Pruritus—Methotrexate—stomach cancer	1.1e-05	0.00036	CcSEcCtD
Pemetrexed—Hypersensitivity—Epirubicin—stomach cancer	1.07e-05	0.00035	CcSEcCtD
Pemetrexed—Urticaria—Doxorubicin—stomach cancer	1.07e-05	0.00035	CcSEcCtD
Pemetrexed—Abdominal pain—Doxorubicin—stomach cancer	1.06e-05	0.000348	CcSEcCtD
Pemetrexed—Body temperature increased—Doxorubicin—stomach cancer	1.06e-05	0.000348	CcSEcCtD
Pemetrexed—Diarrhoea—Methotrexate—stomach cancer	1.06e-05	0.000348	CcSEcCtD
Pemetrexed—Asthenia—Epirubicin—stomach cancer	1.04e-05	0.000341	CcSEcCtD
Pemetrexed—Pruritus—Epirubicin—stomach cancer	1.03e-05	0.000336	CcSEcCtD
Pemetrexed—Dizziness—Methotrexate—stomach cancer	1.03e-05	0.000336	CcSEcCtD
Pemetrexed—Diarrhoea—Epirubicin—stomach cancer	9.94e-06	0.000325	CcSEcCtD
Pemetrexed—Hypersensitivity—Doxorubicin—stomach cancer	9.91e-06	0.000324	CcSEcCtD
Pemetrexed—Vomiting—Methotrexate—stomach cancer	9.87e-06	0.000323	CcSEcCtD
Pemetrexed—Rash—Methotrexate—stomach cancer	9.79e-06	0.00032	CcSEcCtD
Pemetrexed—Dermatitis—Methotrexate—stomach cancer	9.78e-06	0.00032	CcSEcCtD
Pemetrexed—Asthenia—Doxorubicin—stomach cancer	9.65e-06	0.000316	CcSEcCtD
Pemetrexed—Dizziness—Epirubicin—stomach cancer	9.61e-06	0.000314	CcSEcCtD
Pemetrexed—Pruritus—Doxorubicin—stomach cancer	9.51e-06	0.000311	CcSEcCtD
Pemetrexed—Vomiting—Epirubicin—stomach cancer	9.24e-06	0.000302	CcSEcCtD
Pemetrexed—Nausea—Methotrexate—stomach cancer	9.22e-06	0.000302	CcSEcCtD
Pemetrexed—Diarrhoea—Doxorubicin—stomach cancer	9.2e-06	0.000301	CcSEcCtD
Pemetrexed—Rash—Epirubicin—stomach cancer	9.16e-06	0.0003	CcSEcCtD
Pemetrexed—Dermatitis—Epirubicin—stomach cancer	9.15e-06	0.0003	CcSEcCtD
Pemetrexed—Dizziness—Doxorubicin—stomach cancer	8.89e-06	0.000291	CcSEcCtD
Pemetrexed—Nausea—Epirubicin—stomach cancer	8.63e-06	0.000282	CcSEcCtD
Pemetrexed—Vomiting—Doxorubicin—stomach cancer	8.55e-06	0.00028	CcSEcCtD
Pemetrexed—Rash—Doxorubicin—stomach cancer	8.48e-06	0.000277	CcSEcCtD
Pemetrexed—Dermatitis—Doxorubicin—stomach cancer	8.47e-06	0.000277	CcSEcCtD
Pemetrexed—Nausea—Doxorubicin—stomach cancer	7.99e-06	0.000261	CcSEcCtD
Pemetrexed—DHFR—Metabolism—UMPS—stomach cancer	7.46e-06	0.000276	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CHEK2—stomach cancer	7.42e-06	0.000274	CbGpPWpGaD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—MYC—stomach cancer	7.37e-06	0.000272	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—PPP2R1A—stomach cancer	7.34e-06	0.000271	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CA2—stomach cancer	7.3e-06	0.00027	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	7.3e-06	0.00027	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—APEX1—stomach cancer	7.21e-06	0.000267	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PPARG—stomach cancer	7.21e-06	0.000266	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PPP2R1A—stomach cancer	7.19e-06	0.000266	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—NT5E—stomach cancer	7.12e-06	0.000263	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PGAM1—stomach cancer	7.12e-06	0.000263	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CD44—stomach cancer	7.09e-06	0.000262	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—TYMS—stomach cancer	7.05e-06	0.000261	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ALDOB—stomach cancer	7.03e-06	0.00026	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—GSTM1—stomach cancer	6.97e-06	0.000258	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	6.96e-06	0.000257	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	6.95e-06	0.000257	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ECHS1—stomach cancer	6.93e-06	0.000256	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PDHA1—stomach cancer	6.93e-06	0.000256	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—BIRC5—stomach cancer	6.9e-06	0.000255	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—TYMS—stomach cancer	6.86e-06	0.000253	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ALDH7A1—stomach cancer	6.79e-06	0.000251	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PLCE1—stomach cancer	6.79e-06	0.000251	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ALDOB—stomach cancer	6.75e-06	0.00025	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	6.73e-06	0.000249	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—SMAD4—stomach cancer	6.68e-06	0.000247	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—JUN—stomach cancer	6.67e-06	0.000246	CbGpPWpGaD
Pemetrexed—DHFR—Disease—RPL15—stomach cancer	6.62e-06	0.000245	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	6.57e-06	0.000243	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—PPP2R1A—stomach cancer	6.56e-06	0.000243	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—ERCC2—stomach cancer	6.55e-06	0.000242	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ALOX5—stomach cancer	6.54e-06	0.000242	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—FADS1—stomach cancer	6.52e-06	0.000241	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—TYMP—stomach cancer	6.52e-06	0.000241	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—UMPS—stomach cancer	6.51e-06	0.000241	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NPM1—stomach cancer	6.5e-06	0.00024	CbGpPWpGaD
Pemetrexed—GART—Metabolism—ALB—stomach cancer	6.48e-06	0.00024	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—DPYD—stomach cancer	6.43e-06	0.000238	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—FYN—stomach cancer	6.34e-06	0.000234	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—MAPK8—stomach cancer	6.31e-06	0.000233	CbGpPWpGaD
Pemetrexed—DHFR—Disease—RBP4—stomach cancer	6.28e-06	0.000232	CbGpPWpGaD
Pemetrexed—GART—Metabolism—NOS3—stomach cancer	6.2e-06	0.000229	CbGpPWpGaD
Pemetrexed—DHFR—Disease—RPS26—stomach cancer	6.17e-06	0.000228	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—BIRC5—stomach cancer	6.17e-06	0.000228	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—MTHFR—stomach cancer	6.16e-06	0.000228	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PPIA—stomach cancer	6.12e-06	0.000226	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—SREBF2—stomach cancer	6.1e-06	0.000226	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—ERCC2—stomach cancer	6.1e-06	0.000225	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	6.07e-06	0.000224	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ECHS1—stomach cancer	6.05e-06	0.000224	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PDHA1—stomach cancer	6.05e-06	0.000224	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—RORA—stomach cancer	6.03e-06	0.000223	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PPP2R1A—stomach cancer	6.02e-06	0.000223	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—BIRC5—stomach cancer	6.02e-06	0.000222	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CDK4—stomach cancer	5.98e-06	0.000221	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—FGFR2—stomach cancer	5.95e-06	0.00022	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—ALB—stomach cancer	5.93e-06	0.000219	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—GSTP1—stomach cancer	5.91e-06	0.000218	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—PRKCB—stomach cancer	5.88e-06	0.000217	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—HMOX1—stomach cancer	5.83e-06	0.000215	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	5.74e-06	0.000212	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MTHFR—stomach cancer	5.73e-06	0.000212	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—TYMP—stomach cancer	5.69e-06	0.00021	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—FADS1—stomach cancer	5.69e-06	0.00021	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GSTT1—stomach cancer	5.69e-06	0.00021	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—CAV1—stomach cancer	5.68e-06	0.00021	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—APOA1—stomach cancer	5.67e-06	0.00021	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PTGS2—stomach cancer	5.67e-06	0.00021	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ALDOB—stomach cancer	5.65e-06	0.000209	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP2A6—stomach cancer	5.62e-06	0.000208	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	5.58e-06	0.000206	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—TYMS—stomach cancer	5.49e-06	0.000203	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—AKR1C3—stomach cancer	5.47e-06	0.000202	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	5.46e-06	0.000202	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	5.46e-06	0.000202	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—IRS2—stomach cancer	5.45e-06	0.000202	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—GSTM1—stomach cancer	5.43e-06	0.000201	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—BIRC5—stomach cancer	5.38e-06	0.000199	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CDK4—stomach cancer	5.35e-06	0.000198	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ENO1—stomach cancer	5.33e-06	0.000197	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SREBF2—stomach cancer	5.33e-06	0.000197	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CAV1—stomach cancer	5.29e-06	0.000195	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—APOA1—stomach cancer	5.27e-06	0.000195	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—RORA—stomach cancer	5.26e-06	0.000195	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—PRKCB—stomach cancer	5.26e-06	0.000194	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ALOX5—stomach cancer	5.26e-06	0.000194	CbGpPWpGaD
Pemetrexed—DHFR—Disease—AKR1C3—stomach cancer	5.25e-06	0.000194	CbGpPWpGaD
Pemetrexed—DHFR—Disease—RPS19—stomach cancer	5.25e-06	0.000194	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CDK4—stomach cancer	5.22e-06	0.000193	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	5.2e-06	0.000192	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—DPYD—stomach cancer	5.17e-06	0.000191	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	5.16e-06	0.000191	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—PRKCB—stomach cancer	5.13e-06	0.00019	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ENO1—stomach cancer	5.12e-06	0.000189	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—ERCC2—stomach cancer	5.11e-06	0.000189	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—IL6ST—stomach cancer	5.01e-06	0.000185	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PPARG—stomach cancer	5e-06	0.000185	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ALDOB—stomach cancer	4.93e-06	0.000182	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—APC—stomach cancer	4.82e-06	0.000178	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—MTHFR—stomach cancer	4.8e-06	0.000177	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	4.74e-06	0.000175	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CD44—stomach cancer	4.73e-06	0.000175	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDK4—stomach cancer	4.67e-06	0.000172	CbGpPWpGaD
Pemetrexed—DHFR—Disease—RPS6—stomach cancer	4.64e-06	0.000172	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—PRKCB—stomach cancer	4.59e-06	0.00017	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ALOX5—stomach cancer	4.59e-06	0.00017	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	4.58e-06	0.000169	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GSTT1—stomach cancer	4.57e-06	0.000169	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CDKN2A—stomach cancer	4.57e-06	0.000169	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CD44—stomach cancer	4.54e-06	0.000168	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP2A6—stomach cancer	4.52e-06	0.000167	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—DPYD—stomach cancer	4.51e-06	0.000167	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—ALB—stomach cancer	4.49e-06	0.000166	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—IL6R—stomach cancer	4.47e-06	0.000165	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CAV1—stomach cancer	4.43e-06	0.000164	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—APOA1—stomach cancer	4.42e-06	0.000163	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—TP53—stomach cancer	4.4e-06	0.000163	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—AKR1C3—stomach cancer	4.4e-06	0.000163	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—NOS3—stomach cancer	4.3e-06	0.000159	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ENO1—stomach cancer	4.28e-06	0.000158	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HBEGF—stomach cancer	4.27e-06	0.000158	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—SERPINE1—stomach cancer	4.19e-06	0.000155	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CDKN2A—stomach cancer	4.09e-06	0.000151	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CDKN1B—stomach cancer	4.05e-06	0.00015	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—RHOA—stomach cancer	4.04e-06	0.000149	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—IL6—stomach cancer	4.03e-06	0.000149	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PPP2R1A—stomach cancer	4.02e-06	0.000149	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—NOS3—stomach cancer	4e-06	0.000148	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GSTT1—stomach cancer	3.99e-06	0.000147	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CDKN2A—stomach cancer	3.99e-06	0.000147	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP2A6—stomach cancer	3.94e-06	0.000146	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GSTP1—stomach cancer	3.94e-06	0.000146	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PTGS2—stomach cancer	3.93e-06	0.000145	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PPARG—stomach cancer	3.89e-06	0.000144	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—HMOX1—stomach cancer	3.89e-06	0.000144	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CCND1—stomach cancer	3.86e-06	0.000143	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PPP2R1A—stomach cancer	3.86e-06	0.000143	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—AKR1C3—stomach cancer	3.84e-06	0.000142	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CD44—stomach cancer	3.8e-06	0.00014	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—ERBB2—stomach cancer	3.74e-06	0.000138	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ENO1—stomach cancer	3.74e-06	0.000138	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CDKN1A—stomach cancer	3.74e-06	0.000138	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—TYMS—stomach cancer	3.67e-06	0.000136	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PTGS2—stomach cancer	3.66e-06	0.000135	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GSTM1—stomach cancer	3.62e-06	0.000134	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CDKN1B—stomach cancer	3.62e-06	0.000134	CbGpPWpGaD
Pemetrexed—DHFR—Disease—SMAD4—stomach cancer	3.58e-06	0.000132	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDKN2A—stomach cancer	3.57e-06	0.000132	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CDKN1B—stomach cancer	3.53e-06	0.000131	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—ALB—stomach cancer	3.5e-06	0.000129	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PIK3CA—stomach cancer	3.49e-06	0.000129	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CDKN1B—stomach cancer	3.46e-06	0.000128	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CCND1—stomach cancer	3.45e-06	0.000128	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ERCC2—stomach cancer	3.41e-06	0.000126	CbGpPWpGaD
Pemetrexed—DHFR—Disease—FYN—stomach cancer	3.4e-06	0.000126	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CCND1—stomach cancer	3.37e-06	0.000125	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—NOS3—stomach cancer	3.35e-06	0.000124	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CDKN1A—stomach cancer	3.34e-06	0.000123	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CD44—stomach cancer	3.32e-06	0.000123	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ERCC2—stomach cancer	3.27e-06	0.000121	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CDKN1A—stomach cancer	3.26e-06	0.00012	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PPP2R1A—stomach cancer	3.23e-06	0.000119	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—MTHFR—stomach cancer	3.2e-06	0.000118	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CDKN1A—stomach cancer	3.2e-06	0.000118	CbGpPWpGaD
Pemetrexed—DHFR—Disease—FGFR2—stomach cancer	3.19e-06	0.000118	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—MAPK3—stomach cancer	3.18e-06	0.000118	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GSTP1—stomach cancer	3.17e-06	0.000117	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDKN1B—stomach cancer	3.16e-06	0.000117	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—HMOX1—stomach cancer	3.13e-06	0.000116	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—MYC—stomach cancer	3.1e-06	0.000115	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MTHFR—stomach cancer	3.07e-06	0.000114	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PTGS2—stomach cancer	3.06e-06	0.000113	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—MAPK1—stomach cancer	3.03e-06	0.000112	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CCND1—stomach cancer	3.01e-06	0.000111	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CAV1—stomach cancer	2.95e-06	0.000109	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—APOA1—stomach cancer	2.95e-06	0.000109	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—TYMS—stomach cancer	2.95e-06	0.000109	CbGpPWpGaD
Pemetrexed—DHFR—Disease—IRS2—stomach cancer	2.92e-06	0.000108	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDKN1A—stomach cancer	2.91e-06	0.000108	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GSTM1—stomach cancer	2.91e-06	0.000108	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—STAT3—stomach cancer	2.85e-06	0.000105	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—MAPK3—stomach cancer	2.85e-06	0.000105	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CAV1—stomach cancer	2.83e-06	0.000105	CbGpPWpGaD
Pemetrexed—DHFR—Disease—APOA1—stomach cancer	2.83e-06	0.000105	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PPP2R1A—stomach cancer	2.82e-06	0.000104	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—MAPK3—stomach cancer	2.78e-06	0.000103	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—MYC—stomach cancer	2.77e-06	0.000102	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GSTP1—stomach cancer	2.77e-06	0.000102	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ERCC2—stomach cancer	2.74e-06	0.000101	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—HMOX1—stomach cancer	2.73e-06	0.000101	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MAPK3—stomach cancer	2.72e-06	0.000101	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—MAPK1—stomach cancer	2.71e-06	0.0001	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—MYC—stomach cancer	2.7e-06	9.99e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—IL6ST—stomach cancer	2.69e-06	9.93e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MYC—stomach cancer	2.65e-06	9.8e-05	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—MAPK1—stomach cancer	2.64e-06	9.77e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PPARG—stomach cancer	2.6e-06	9.6e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MAPK1—stomach cancer	2.59e-06	9.58e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—EGFR—stomach cancer	2.59e-06	9.58e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—APC—stomach cancer	2.58e-06	9.55e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—MTHFR—stomach cancer	2.57e-06	9.51e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GSTM1—stomach cancer	2.54e-06	9.39e-05	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—MAPK3—stomach cancer	2.48e-06	9.19e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—KRAS—stomach cancer	2.45e-06	9.05e-05	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PIK3CA—stomach cancer	2.42e-06	8.94e-05	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—MYC—stomach cancer	2.42e-06	8.93e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—IL6R—stomach cancer	2.4e-06	8.86e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ERCC2—stomach cancer	2.39e-06	8.83e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CAV1—stomach cancer	2.37e-06	8.78e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—APOA1—stomach cancer	2.37e-06	8.76e-05	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—MAPK1—stomach cancer	2.36e-06	8.74e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ALB—stomach cancer	2.34e-06	8.63e-05	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—TP53—stomach cancer	2.27e-06	8.41e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PIK3CA—stomach cancer	2.25e-06	8.32e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—MTHFR—stomach cancer	2.25e-06	8.3e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—SERPINE1—stomach cancer	2.24e-06	8.3e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—NOS3—stomach cancer	2.23e-06	8.26e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—RHOA—stomach cancer	2.17e-06	8.01e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NOS3—stomach cancer	2.14e-06	7.92e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PPARG—stomach cancer	2.09e-06	7.72e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—HRAS—stomach cancer	2.08e-06	7.69e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CAV1—stomach cancer	2.07e-06	7.66e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—APOA1—stomach cancer	2.07e-06	7.64e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PTGS2—stomach cancer	2.04e-06	7.55e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ERBB2—stomach cancer	2e-06	7.41e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—IL6—stomach cancer	1.99e-06	7.36e-05	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—TP53—stomach cancer	1.98e-06	7.34e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PTGS2—stomach cancer	1.96e-06	7.25e-05	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PIK3CA—stomach cancer	1.88e-06	6.96e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ALB—stomach cancer	1.88e-06	6.94e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CDKN1B—stomach cancer	1.86e-06	6.86e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PPARG—stomach cancer	1.82e-06	6.73e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—NOS3—stomach cancer	1.79e-06	6.64e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CDKN1A—stomach cancer	1.71e-06	6.33e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PTGS2—stomach cancer	1.64e-06	6.07e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ALB—stomach cancer	1.64e-06	6.05e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—NOS3—stomach cancer	1.57e-06	5.79e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—STAT3—stomach cancer	1.53e-06	5.65e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MAPK3—stomach cancer	1.46e-06	5.4e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PTGS2—stomach cancer	1.43e-06	5.3e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MYC—stomach cancer	1.42e-06	5.25e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MAPK1—stomach cancer	1.39e-06	5.14e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—EGFR—stomach cancer	1.39e-06	5.14e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—KRAS—stomach cancer	1.31e-06	4.85e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PIK3CA—stomach cancer	1.26e-06	4.65e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PIK3CA—stomach cancer	1.21e-06	4.46e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HRAS—stomach cancer	1.12e-06	4.13e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—IL6—stomach cancer	1.07e-06	3.95e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PIK3CA—stomach cancer	1.01e-06	3.73e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PIK3CA—stomach cancer	8.81e-07	3.26e-05	CbGpPWpGaD
